European countries are looking at buying millions of COVID-19 rapid tests mostly from Roche and Abbott , an EU document shows, as global production of the tests is stretched by a surge in infections.

Surging COVID-19 cases globally will necessitate a shift to more testing with cheap, less-accurate antigen tests because more-accurate molecular, or PCR, tests are in short supply, the Swiss drugmaker ...